Atlas Trials

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Clinical trial NCT03746275 · COMPLETED

Trial details

NCT number
NCT03746275
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Atherosclerosis
Start date
2018-11-13
Primary completion
2021-06-08
Enrollment
5798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.